These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8278307)

  • 21. A photophysical and photochemical study of 6-methoxy-2-naphthylacetic acid, the major metabolite of the phototoxic nonsteroidal antiinflammatory drug nabumetone.
    Boscá F; Canudas N; Marín ML; Miranda MA
    Photochem Photobiol; 2000 Feb; 71(2):173-7. PubMed ID: 10687391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions of antirheumatic drugs with the superoxide generation system of activated human polymorphonuclear leukocytes.
    Minta JO; Williams MD
    J Rheumatol; 1986 Jun; 13(3):498-504. PubMed ID: 3016258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radical scavenger activity of phenylethanoid glycosides in FMLP stimulated human polymorphonuclear leukocytes: structure-activity relationships.
    Heilmann J; Calis I; Kirmizibekmez H; Schühly W; Harput S; Sticher O
    Planta Med; 2000 Dec; 66(8):746-8. PubMed ID: 11199133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High concentrations of histamine stimulate equine polymorphonuclear neutrophils to produce reactive oxygen species.
    Benbarek H; Mouithys-Mickalad A; Deby-Dupont G; Deby C; Grülke S; Nemmar A; Lamy M; Serteyn D
    Inflamm Res; 1999 Nov; 48(11):594-601. PubMed ID: 10598016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiinflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6-methoxy-2-naphthylacetic acid (6MNA). Comparative studies with indomethacin.
    Melarange R; Gentry C; O'Connell C; Blower PR; Neil C; Kelvin AS; Toseland CD
    Dig Dis Sci; 1992 Dec; 37(12):1847-52. PubMed ID: 1473433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotactic peptide activation of human neutrophils and HL-60 cells. Pertussis toxin reveals correlation between inositol trisphosphate generation, calcium ion transients, and cellular activation.
    Krause KH; Schlegel W; Wollheim CB; Andersson T; Waldvogel FA; Lew PD
    J Clin Invest; 1985 Oct; 76(4):1348-54. PubMed ID: 3877077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zymosan induces NADPH oxidase activation in human neutrophils by inducing the phosphorylation of p47phox and the activation of Rac2: involvement of protein tyrosine kinases, PI3Kinase, PKC, ERK1/2 and p38MAPkinase.
    Makni-Maalej K; Chiandotto M; Hurtado-Nedelec M; Bedouhene S; Gougerot-Pocidalo MA; Dang PM; El-Benna J
    Biochem Pharmacol; 2013 Jan; 85(1):92-100. PubMed ID: 23085266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exposure of human neutrophils to chemotactic factors potentiates activation of the respiratory burst enzyme.
    Bender JG; McPhail LC; Van Epps DE
    J Immunol; 1983 May; 130(5):2316-23. PubMed ID: 6300243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Penetration of the active metabolite of nabumetone into synovial fluid and adherent tissue of patients undergoing knee joint surgery.
    Miehlke RK; Schneider S; Sörgel F; Muth P; Henschke F; Giersch KH; Münzel P
    Drugs; 1990; 40 Suppl 5():57-61. PubMed ID: 2081495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human neutrophil oxidative bursts and their in vitro modulation by different N-acetylcysteine concentrations.
    Allegra L; Dal Sasso M; Bovio C; Massoni C; Fonti E; Braga PC
    Arzneimittelforschung; 2002; 52(9):669-76. PubMed ID: 12404881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unsaturated fatty acids and lipoxygenase products regulate phagocytic NADPH oxidase activity by a nondetergent mechanism.
    Corey SJ; Rosoff PM
    J Lab Clin Med; 1991 Oct; 118(4):343-51. PubMed ID: 1940576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro interaction between spiramycin and polymorphonuclear neutrophils oxidative metabolism.
    Moutard I; Gressier B; Brunet C; Dine T; Luyckx M; Templier F; Cazin M; Cazin JC
    Pharmacol Res; 1998 Mar; 37(3):197-201. PubMed ID: 9602467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A metabolic pathway for the prodrug nabumetone to the pharmacologically active metabolite, 6-methoxy-2-naphthylacetic acid (6-MNA) by non-cytochrome P450 enzymes.
    Matsumoto K; Hasegawa T; Ohara K; Takei C; Kamei T; Koyanagi J; Takahashi T; Akimoto M
    Xenobiotica; 2020 Jul; 50(7):783-792. PubMed ID: 31855101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nabumetone pharmacokinetics in patients with varying degrees of renal impairment.
    Boelaert JR; Jonnaert HA; Daneels RF; Schurgers ML; Thawley AR; Undre NA; Cooper DL
    Am J Med; 1987 Oct; 83(4B):107-9. PubMed ID: 3687998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of human neutrophils by Mycobacterium tuberculosis-derived sulfolipid-1.
    Zhang L; English D; Andersen BR
    J Immunol; 1991 Apr; 146(8):2730-6. PubMed ID: 1849937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of a guanine nucleotide regulatory protein in the activation of phospholipase C by different chemoattractants.
    Verghese MW; Charles L; Jakoi L; Dillon SB; Snyderman R
    J Immunol; 1987 Jun; 138(12):4374-80. PubMed ID: 3108387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolism of nabumetone (BRL 14777) by various species including man.
    Haddock RE; Jeffery DJ; Lloyd JA; Thawley AR
    Xenobiotica; 1984 Apr; 14(4):327-37. PubMed ID: 6464502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on opsonized zymozan, FMLP, carbachol, PMA and A23187 stimulated respiratory burst of human PMNLs.
    Fülöp T; Varga Z; Nagy JT; Fóris G
    Biochem Int; 1988 Sep; 17(3):419-26. PubMed ID: 2849440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reactive oxygen species production in circulating polymorphonuclear leukocytes in psoriasis.
    De Simone C; De Sole P; Di Mario G; Venier A; Cerimele D; Serri F
    Acta Derm Venereol Suppl (Stockh); 1989; 146():50-2. PubMed ID: 2609883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of hydroxyimine as cytochrome P450-selective prodrug structure.
    Kumpulainen H; Mähönen N; Laitinen ML; Jaurakkajärvi M; Raunio H; Juvonen RO; Vepsäläinen J; Järvinen T; Rautio J
    J Med Chem; 2006 Feb; 49(3):1207-11. PubMed ID: 16451086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.